The purpose of this study is to conduct an investigator initiated observational study to continue to follow up the China subset of study participants for another 5 years after they complete participation in the REALM Study
Study Type
OBSERVATIONAL
Enrollment
4,000
Treatment patterns in Study AI463520
Time frame: year 5
Incidence rates of hepatitis B virus (HBV)-related clinical outcome events (COEs), such as non-hepatocellular carcinoma (HCC) HBV progression, HCC, and liver-related mortality, in Studies AI463080 and AI463520 combined, and in Study AI463520.
Time frame: year 5
Antiviral efficacy endpoints on anti-HBV treatment in Studies AI463080 and AI463520.
Time frame: year 5
Multivariate logistic regression models evaluating the relationship between pre-treatment biomarkers and antiviral efficacy endpoints on anti-HBV treatment in Study
Time frame: year 5
Multivariate logistic regression models evaluating the relationship between baseline liver stiffness measurement (LSM) and HBV-related COEs outcomes in Study AI463520.
Time frame: year 5
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
First Affiliated Hospital of Anhui Medical University
Hefei, Anhui, China
RECRUITING302 Military Hospital Of China
Beijing, Beijing Municipality, China
RECRUITINGBeijing Ditan Hospital
Beijing, Beijing Municipality, China
RECRUITINGBeijing Friendship Hospital
Beijing, Beijing Municipality, China
RECRUITINGPeople's Hospital of Beijing University
Beijing, Beijing Municipality, China
RECRUITINGThe Second Affiliated of ChongQing University of Medical Science
Chongqing, Chongqing Municipality, China
RECRUITINGGuangZhou No. 8 People's Hospital
Guangzhou, Guangdong, China
RECRUITINGNanfang Hospital
Guangzhou, Guangdong, China
RECRUITINGThird Affiliated Hospital of Sun Yat-sen University
Guangzhou, Guangdong, China
RECRUITINGAffiliated Hospital of Guiyang Medical College
Guiyang, Guizhou, China
RECRUITING...and 40 more locations